- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Epigral Limited — Updates, 27-07-2026: Press Release
27-07-2026 | 02:15 pm
27-07-2026 | 02:15 pm
Epigral reported Q1FY27 PAT up 25% to ₹99 Cr, with revenue up 15% to ₹709 Cr. The board approved ₹600 Cr capex for a 1,25,000 TPA Epoxy Resin & Formulations plant and a Multi-Purpose Plant, targeting H2FY28 commissioning, leveraging internal raw materials.
No comments yet. Be the first to comment!